BRETYLIUM TOSYLATE — all Canadian products
5 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BRETYLIUM TOSYLATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00519243 | BRETYLATE INJ 50MG/ML | GLAXO WELLCOME INC. | Liquid | Intravenous; Intramuscular | BRETYLIUM TOSYLATE 50 MG | Cancelled Post Market | |
| 00655716 | BRETYLIUM TOSYLATE 0.2% AND DEXTROSE 5% INJ | ABBOTT LABORATORIES, LIMITED | Solution | Intravenous | BRETYLIUM TOSYLATE 2 MG; DEXTROSE 50 MG | Cancelled Post Market | |
| 00655724 | BRETYLIUM TOSYLATE 0.4% AND DEXTROSE 5% INJ | ABBOTT LABORATORIES, LIMITED | Solution | Intravenous | BRETYLIUM TOSYLATE 4 MG; DEXTROSE 50 MG | Cancelled Post Market | |
| 00786594 | BRETYLIUM TOSYLATE INJ 50MG/ML | ABBOTT LABORATORIES, LIMITED | Solution | Intramuscular; Intravenous | BRETYLIUM TOSYLATE 50 MG | Cancelled Post Market | |
| 02185377 | BRETYLIUM TOSYLATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intramuscular; Intravenous | BRETYLIUM TOSYLATE 50 MG | Cancelled Post Market |
Browse other molecules: